Skip to content
★ Sign in to follow
BL
Total declarations
34
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€2.5M

Latest filing published 26 Aug 2019 for Catalent, Inc..

Filing timeline

BuySale
Barry Littlejohns

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Barry Littlejohns: trading record in brief

All filings by Barry Littlejohns on record concern Catalent, Inc. We count 34 filings; the first trade dates from 27 August 2015 and the latest from 22 August 2019.

The open-market record consists of 3 sales worth €2.5M, with no purchase. The rest of the record consists of 23 share grants and 8 option exercises. 2019 to date brings no purchases and 2 sales.

The newest entry dates from 26 August 2019: a share grant of €358k, in Catalent, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Barry Littlejohns

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations33 total
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    0SEC
    14,573 shares0Common StockSEC:0001596783-19-000162:0
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    396,513 USD22SEC
    7,178 shares@ US$55.243.3% of flowCommon StockSEC:0001596783-19-000162:1
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    70,659 USD22SEC
    1,234 shares@ US$57.260.6% of flowCommon StockSEC:0001596783-19-000104:0
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    0SEC
    2,003 shares0Common StockSEC:0001596783-19-000081:0
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    744,420 USD23SEC
    13,904 shares@ US$53.546.1% of flowCommon StockSEC:0001596783-19-000059:7
  • ▼
    President, Biologics & SDDExecutivesCatalent, Inc.
    847,915 USD35SEC
    15,840 shares@ US$53.537.0% of flowCommon StockSEC:0001596783-19-000059:8
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    324,975 USD22SEC
    17,500 shares@ US$18.572.7% of flowCommon StockSEC:0001596783-19-000059:0
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    626,418 USD23SEC
    11,700 shares@ US$53.545.2% of flowCommon StockSEC:0001596783-19-000059:1
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    125,607 USD22SEC
    6,764 shares@ US$18.571.0% of flowCommon StockSEC:0001596783-19-000059:2
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    242,161 USD22SEC
    4,523 shares@ US$53.542.0% of flowCommon StockSEC:0001596783-19-000059:3
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    87,353 USD22SEC
    4,704 shares@ US$18.570.7% of flowCommon StockSEC:0001596783-19-000059:4
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    168,383 USD22SEC
    3,145 shares@ US$53.541.4% of flowCommon StockSEC:0001596783-19-000059:5
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    415,002 USD22SEC
    20,244 shares@ US$20.503.4% of flowCommon StockSEC:0001596783-19-000059:6
  • ▼
    President, Biologics & SDDExecutivesCatalent, Inc.
    5,429 USD34SEC
    100 shares@ US$54.290.0% of flowCommon StockSEC:0001596783-19-000059:9
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    1M USD23SEC
    87,500 shares@ US$14.8610.4% of flowCommon StockSEC:0001596783-18-000156:0
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    2M USD24SEC
    58,940 shares@ US$41.6419.7% of flowCommon StockSEC:0001596783-18-000156:1
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    347,843 USD22SEC
    23,408 shares@ US$14.862.8% of flowCommon StockSEC:0001596783-18-000156:2
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    656,580 USD23SEC
    15,768 shares@ US$41.645.3% of flowCommon StockSEC:0001596783-18-000156:3
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    71,075 USD22SEC
    4,783 shares@ US$14.860.6% of flowCommon StockSEC:0001596783-18-000156:4
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    134,164 USD22SEC
    3,222 shares@ US$41.641.1% of flowCommon StockSEC:0001596783-18-000156:5
  • ◇
    President, Biologics & SDDExecutivesCatalent, Inc.
    432,723 USD22SEC
    29,120 shares@ US$14.863.5% of flowCommon StockSEC:0001596783-18-000156:6
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    816,810 USD23SEC
    19,616 shares@ US$41.646.5% of flowCommon StockSEC:0001596783-18-000156:7
  • ▼
    President, Biologics & SDDExecutivesCatalent, Inc.
    2M USD36SEC
    47,265 shares@ US$41.6415.8% of flowCommon StockSEC:0001596783-18-000156:8
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    41,215 USD22SEC
    944 shares@ US$43.660.3% of flowCommon StockSEC:0001596783-18-000119:0
  • ◆
    President, Biologics & SDDExecutivesCatalent, Inc.
    0SEC
    5,943 shares0Common StockSEC:0001596783-18-000095:0

25 of 33 declarations